Vanguard Personalized Indexing Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,764
Closed -$1.16M 1989
2025
Q2
$1.16M Buy
11,764
+4,028
+52% +$381K 0.01% 807
2025
Q1
$717K Buy
7,736
+1,683
+28% +$155K 0.01% 945
2024
Q4
$550K Sell
6,053
-78
-1% -$7.16K 0.01% 1066
2024
Q3
$592K Buy
6,131
+710
+13% +$69.3K 0.01% 1019
2024
Q2
$498K Buy
5,421
+619
+13% +$57.4K 0.01% 1037
2024
Q1
$443K Sell
4,802
-228
-5% -$21.4K 0.01% 1083
2023
Q4
$478K Sell
5,030
-892
-15% -$83.3K 0.01% 1021
2023
Q3
$553K Buy
5,922
+1,304
+28% +$120K 0.02% 835
2023
Q2
$422K Buy
4,618
+200
+5% +$16.4K 0.01% 964
2023
Q1
$325K Buy
+4,418
New +$382K 0.01% 1084
2022
Q2
Sell
-1,323
Closed -$227K 1264
2022
Q1
$227K Buy
+1,323
New +$198K 0.01% 1075
2021
Q4
Sell
-1,697
Closed -$253K 1061
2021
Q3
$253K Buy
+1,697
New +$353K 0.02% 846

Other funds holding AMED

Vanguard Personalized Indexing Management's AMED Position: Q3 2025 in Review

Vanguard Personalized Indexing Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 11,764 shares — an estimated $1.16M sold.

Vanguard Personalized Indexing Management first reported a position in AMED in Q3 2021 and held it in 12 quarters. The position peaked at $1.16M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Vanguard Personalized Indexing Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 11,764 Amedisys shares in Q3 2025, an estimated $1.16M.
  • Vanguard Personalized Indexing Management first reported a position in Amedisys in Q3 2021 and held it in 12 quarters.
  • Vanguard Personalized Indexing Management's Amedisys position peaked at $1.16M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q3 2025, filed 31 Oct 2025.